JPH11513562A - 組換えプラスミドの生産方法 - Google Patents

組換えプラスミドの生産方法

Info

Publication number
JPH11513562A
JPH11513562A JP9515377A JP51537797A JPH11513562A JP H11513562 A JPH11513562 A JP H11513562A JP 9515377 A JP9515377 A JP 9515377A JP 51537797 A JP51537797 A JP 51537797A JP H11513562 A JPH11513562 A JP H11513562A
Authority
JP
Japan
Prior art keywords
plasmid
cells
cell
gene
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP9515377A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11513562A5 (2
Inventor
エイ． モージー，モハマド
Original Assignee
バイオスター，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオスター，インコーポレイテッド filed Critical バイオスター，インコーポレイテッド
Publication of JPH11513562A publication Critical patent/JPH11513562A/ja
Publication of JPH11513562A5 publication Critical patent/JPH11513562A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP9515377A 1995-10-17 1996-10-17 組換えプラスミドの生産方法 Ceased JPH11513562A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54805995A 1995-10-17 1995-10-17
US56497395A 1995-11-30 1995-11-30
US08/564,973 1995-11-30
US08/548,059 1995-11-30
PCT/CA1996/000693 WO1997014805A2 (en) 1995-10-17 1996-10-17 Methods for production of recombinant plasmids

Publications (2)

Publication Number Publication Date
JPH11513562A true JPH11513562A (ja) 1999-11-24
JPH11513562A5 JPH11513562A5 (2) 2004-10-14

Family

ID=27068752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9515377A Ceased JPH11513562A (ja) 1995-10-17 1996-10-17 組換えプラスミドの生産方法

Country Status (9)

Country Link
US (1) US5922583A (2)
EP (1) EP0856059B1 (2)
JP (1) JPH11513562A (2)
AT (1) ATE247713T1 (2)
AU (1) AU7208896A (2)
CA (1) CA2232234A1 (2)
DE (1) DE69629576T2 (2)
TW (1) TW514667B (2)
WO (1) WO1997014805A2 (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007511236A (ja) * 2003-11-20 2007-05-10 コブラ バイオロジックス リミテッド プラスミドの維持
JP2008512998A (ja) * 2004-09-17 2008-05-01 ベーリンガー インゲルハイム オーストリア ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗生物質フリーのＣｏ１Ｅ１プラスミドを増殖するための宿主ベクター系
JP2014064579A (ja) * 2001-02-23 2014-04-17 Universite Libre De Bruxelles 毒性分子に対する抗毒性蛋白質をコードする配列を含む組換体クローンの選択方法

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006085A3 (fr) * 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
AU766257C (en) * 1998-05-07 2004-06-03 Universite Libre De Bruxelles Cytotoxin-based biological containment
WO2000028048A1 (en) * 1998-11-09 2000-05-18 Genecare Development Aps Novel plasmids for use in medicine and method of producing same
EP1135025B1 (en) * 1998-12-02 2007-04-25 University of Maryland, Baltimore Plasmid maintenance system for antigen delivery
US6413768B1 (en) 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US8076130B2 (en) * 1998-12-02 2011-12-13 University Of Maryland, Baltimore Plasmid maintenance system for antigen delivery
US6423545B1 (en) * 1999-07-08 2002-07-23 Albert Einstein College Of Medicine Of Yeshiva University Unmarked deletion mutants of mycobacteria and methods of using same
EP1111061A1 (en) * 1999-12-20 2001-06-27 Universite Libre De Bruxelles Double selection vector
US9012141B2 (en) * 2000-03-27 2015-04-21 Advaxis, Inc. Compositions and methods comprising KLK3 of FOLH1 antigen
US7396822B2 (en) * 2001-05-24 2008-07-08 Vaxiion Therapeutics, Inc. Immunogenic minicells and methods of use
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
US20030224369A1 (en) * 2002-02-25 2003-12-04 Surber Mark W. Reverse screening and target identification with minicells
US20030207833A1 (en) * 2002-02-25 2003-11-06 Neil Berkley Pharmaceutical compositions with minicells
US20030224444A1 (en) * 2002-02-25 2003-12-04 Sabbadini Roger A. Antibodies to native conformations of membrane proteins
US20050260585A1 (en) * 2002-03-19 2005-11-24 Cedric Szpirer Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
US20040005700A1 (en) * 2002-05-28 2004-01-08 Surber Mark W. Poroplasts
US9309518B2 (en) 2002-09-03 2016-04-12 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
WO2004022745A2 (en) * 2002-09-03 2004-03-18 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
WO2006055024A2 (en) * 2004-04-05 2006-05-26 Vaxiion Therapeutics, Inc. Minicells as vaccines
US8906664B2 (en) 2004-08-13 2014-12-09 The Trustees Of The University Of Pennsylvania Methods for constructing antibiotic resistance free vaccines
CN1912127B (zh) * 2005-08-08 2011-05-25 百瑞全球有限公司 一种大肠杆菌表达载体及其应用
EP2152889B1 (en) 2007-05-29 2017-03-15 Nature Technology Corporation Vectors and methods for genetic immunization
US20120135033A1 (en) * 2008-05-19 2012-05-31 Anu Wallecha Multiple delivery system for heterologous antigens
US9017660B2 (en) 2009-11-11 2015-04-28 Advaxis, Inc. Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
US9650639B2 (en) 2008-05-19 2017-05-16 Advaxis, Inc. Dual delivery system for heterologous antigens
US20110129499A1 (en) * 2008-05-19 2011-06-02 Paulo Maciag Dual delivery system for heterologous antigens
US10016617B2 (en) 2009-11-11 2018-07-10 The Trustees Of The University Of Pennsylvania Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
EP2498808A4 (en) * 2009-11-11 2014-01-08 Advaxis COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
US9226958B2 (en) 2010-10-01 2016-01-05 University Of Georgia Research Foundation, Inc. Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
ES2720659T3 (es) 2011-02-15 2019-07-23 Vaxiion Therapeutics Llc Composiciones terapéuticas y métodos para la administración dirigida, mediante minicélulas bacterianas, de moléculas bioactivas basadas en moléculas dirigidas que contienen Fc y anticuerpos
AU2012229218B2 (en) 2011-03-11 2017-03-02 Advaxis, Inc. Listeria-based adjuvants
CN104411327A (zh) 2012-03-12 2015-03-11 阿德瓦希斯公司 李斯特菌疫苗治疗以后的抑制细胞功能抑制
US9550998B2 (en) 2012-08-29 2017-01-24 Nature Technology Corporation DNA plasmids with improved expression
US20150322439A1 (en) 2012-11-19 2015-11-12 Nature Technology Corporation Replicative minicircle vectors with improved expression
WO2015024855A1 (en) 2013-08-19 2015-02-26 Syngulon Sa Controlled growth of microorganisms
WO2019057774A1 (en) 2017-09-19 2019-03-28 Deutsches Krebsforschungszentrum NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS
EP3456821B2 (en) 2017-09-19 2024-01-24 Deutsches Krebsforschungszentrum Non-integrating dna vectors for the genetic modification of cells
US11932672B2 (en) 2017-12-19 2024-03-19 Syngulon S.A. Fermentation process
WO2019183248A1 (en) 2018-03-21 2019-09-26 Nature Technology Corporation Viral and non-viral nanoplasmid vectors with improved production
WO2025160245A1 (en) 2024-01-25 2025-07-31 Aldevron, L.L.C. Viral and non-viral nanoplasmid vectors with improved production
WO2025231315A2 (en) 2024-05-03 2025-11-06 Aldevron, L.L.C. Bacterial host strains
WO2026076187A1 (en) 2024-10-03 2026-04-09 Aldevron, L.L.C. Compositions and methods for microbial production of antibiotic-free closed-ended linear dna

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
US4968619A (en) * 1976-09-27 1990-11-06 Research Corporation Modified microorganisms and method of preparing and using same
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4837151A (en) * 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US5702916A (en) * 1982-09-16 1997-12-30 Gx Biosystems A/S Biological Containment
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
FR2568891B1 (fr) * 1984-08-09 1988-05-27 Transgene Sa Procede de preparation d'une souche, notamment de levure, transformee par un vecteur d'expression, qui peut etre cultivee sur un milieu complet sans pression de selection et souche ainsi obtenue
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
GB2177097A (en) * 1985-06-18 1987-01-14 Genencor Inc Stable maintenance of nucleic acid in recombinant cells
DK275685D0 (da) * 1985-06-18 1985-06-18 Benzon As Alfred Stabilisering af biologiske systemer
US5387744A (en) * 1987-06-04 1995-02-07 Washington University Avirulent microbes and uses therefor: Salmonella typhi
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5294441A (en) * 1987-06-04 1994-03-15 Washington University Avirulent microbes and uses therefor: salmonella typhi
ATE121785T1 (de) * 1987-10-07 1995-05-15 Univ Washington Verfahren zur erhaltung eines erwünschten rekombinanten gens in einer genetischen zellpopulation.
WO1990002484A1 (en) * 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
EP0465560B1 (en) * 1989-03-31 1996-06-05 Washington University VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS
IL93957A0 (en) * 1989-03-31 1990-12-23 Univ Washington Bordetella outer membrane proteins,their use in vaccines and their expression
WO1990011688A1 (en) * 1989-03-31 1990-10-18 Washington University Avirulent microbes and uses therefor
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
EP0500699B1 (en) * 1989-11-03 1998-06-10 Washington University Cross-protective salmonella vaccines
ATE177787T1 (de) * 1990-11-21 1999-04-15 Univ Washington Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
AU6705594A (en) * 1993-04-15 1994-11-08 Washington University Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014064579A (ja) * 2001-02-23 2014-04-17 Universite Libre De Bruxelles 毒性分子に対する抗毒性蛋白質をコードする配列を含む組換体クローンの選択方法
JP2007511236A (ja) * 2003-11-20 2007-05-10 コブラ バイオロジックス リミテッド プラスミドの維持
JP2008512998A (ja) * 2004-09-17 2008-05-01 ベーリンガー インゲルハイム オーストリア ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗生物質フリーのＣｏ１Ｅ１プラスミドを増殖するための宿主ベクター系

Also Published As

Publication number Publication date
US5922583A (en) 1999-07-13
CA2232234A1 (en) 1997-04-24
DE69629576D1 (de) 2003-09-25
ATE247713T1 (de) 2003-09-15
WO1997014805A2 (en) 1997-04-24
EP0856059B1 (en) 2003-08-20
TW514667B (en) 2002-12-21
AU7208896A (en) 1997-05-07
DE69629576T2 (de) 2004-06-24
WO1997014805A3 (en) 1997-06-12
EP0856059A1 (en) 1998-08-05

Similar Documents

Publication Publication Date Title
JPH11513562A (ja) 組換えプラスミドの生産方法
US20040106118A1 (en) Method for exposing peptides and polypeptides on the cell surface of bacteria
JP2001503274A (ja) 改良された発現ベクター
JP3976685B2 (ja) タンパク質分泌のためのＣｌｙＡ溶血素の使用
JPH07506240A (ja) コレラトキシンの免疫原性無毒化変異体およびトキシンｌｔの免疫原性無毒化変異体，それらの調製，ならびにワクチンの調製のためのそれらの使用
JPH11235191A (ja) 細胞の遺伝的集団において所望の組換え遺伝子を維持する方法
JPH07278195A (ja) 組み換えｇ−ｃｓｆ
JPH0138475B2 (2)
CN102083975A (zh) 小环dna载体制剂及其制备方法和使用方法
JPH0376580A (ja) 大腸菌発現ベクターとそれを利用した抗ウイルス性タンパク質の製造方法
JPH05192161A (ja) 安定ｐｕｒＡベクターおよびそれらの使用
US20110129487A1 (en) Plasmic production and expression of recombinant proteins in cells grown without antibiotics
IL275843B1 (en) Auexotropic strains of Staphylococcus bacteria
WO1994000463A2 (en) Production of hyaluronic acid by transeformed microorganisms
CN115873852B (zh) 重组核酸序列、基因工程菌及生产1,5-戊二胺的方法
JP3620831B2 (ja) 乳酸菌シャトルベクター
JPS5951793A (ja) 新規クロ−ニングビヒクル
US20050153398A1 (en) Flavobacterium heparinum expression system
CN100359001C (zh) 宿主细胞中重组多肽的区室化
US7049097B2 (en) Antibiotics-independent vector for constant high-expression and method for gene expression using the same
JP2023139192A (ja) Ｃｒｍ１９７タンパク質発現方法
Engel et al. Enzymatic preparation of 1, 6-anhydro-muropeptides by immobilized murein hydrolases from Escherichia coli fused to staphylococcal protein A
US7087410B2 (en) Systems for expression of heterologous proteins in M. capsulatus
KR100434108B1 (ko) L-트립토판의유전공학적제조방법
JPS58501406A (ja) エシエリヒア・コリ−における蛋白合成発現の高揚

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060530

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20061016

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061121